289 related articles for article (PubMed ID: 19485704)
21. Epidemiological and molecular mechanisms aspects linking obesity and cancer.
Osório-Costa F; Rocha GZ; Dias MM; Carvalheira JB
Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):213-26. PubMed ID: 19466214
[TBL] [Abstract][Full Text] [Related]
22. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms.
Calle EE; Kaaks R
Nat Rev Cancer; 2004 Aug; 4(8):579-91. PubMed ID: 15286738
[No Abstract] [Full Text] [Related]
23. The role of hyperglycaemia and hyperinsulinaemia in causing vascular dysfunction in diabetes.
King GL
Ann Med; 1996 Oct; 28(5):427-32. PubMed ID: 8949974
[TBL] [Abstract][Full Text] [Related]
24. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance.
Tabata M; Kadomatsu T; Fukuhara S; Miyata K; Ito Y; Endo M; Urano T; Zhu HJ; Tsukano H; Tazume H; Kaikita K; Miyashita K; Iwawaki T; Shimabukuro M; Sakaguchi K; Ito T; Nakagata N; Yamada T; Katagiri H; Kasuga M; Ando Y; Ogawa H; Mochizuki N; Itoh H; Suda T; Oike Y
Cell Metab; 2009 Sep; 10(3):178-88. PubMed ID: 19723494
[TBL] [Abstract][Full Text] [Related]
25. [Persistent hyperglycemia and hyperinsulinemia in a newborn infant].
Tapia Ceballos L; Romero Sánchez J; Picazo Angelin B; Díaz Cabrera R; Romero González J
An Esp Pediatr; 2001 May; 54(5):497-501. PubMed ID: 11333480
[TBL] [Abstract][Full Text] [Related]
26. Curcumin molecular targets in obesity and obesity-related cancers.
Shehzad A; Khan S; Sup Lee Y
Future Oncol; 2012 Feb; 8(2):179-90. PubMed ID: 22335582
[TBL] [Abstract][Full Text] [Related]
27. [Obesity, insulin resistance and type 2 diabetes: risk factors for breast cancer].
Scheen AJ; Beck E; De Flines J; Rorive M
Rev Med Liege; 2011; 66(5-6):238-44. PubMed ID: 21826954
[TBL] [Abstract][Full Text] [Related]
28. Influence of obesity on breast cancer receptor status and prognosis.
Rose DP; Vona-Davis L
Expert Rev Anticancer Ther; 2009 Aug; 9(8):1091-101. PubMed ID: 19671029
[TBL] [Abstract][Full Text] [Related]
29. Nutrition, metabolic factors and cancer risk.
Dossus L; Kaaks R
Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):551-71. PubMed ID: 18971118
[TBL] [Abstract][Full Text] [Related]
30. Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia.
Esser N; Utzschneider KM; Kahn SE
Diabetologia; 2020 Oct; 63(10):2007-2021. PubMed ID: 32894311
[TBL] [Abstract][Full Text] [Related]
31. [Role of obesity in colorectal carcinogenesis].
Hagymási K; Tulassay Z
Orv Hetil; 2007 Dec; 148(51):2411-6. PubMed ID: 18055394
[TBL] [Abstract][Full Text] [Related]
32. [Expression of omentin in adipose tissues in obese and type 2 diabetic patients].
Cai RC; Wei L; DI JZ; Yu HY; Bao YQ; Jia WP
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):381-4. PubMed ID: 19567114
[TBL] [Abstract][Full Text] [Related]
33. Symposium 1: Overnutrition: consequences and solutions. Obesity and cancer risk.
Key TJ; Spencer EA; Reeves GK
Proc Nutr Soc; 2010 Feb; 69(1):86-90. PubMed ID: 19954565
[TBL] [Abstract][Full Text] [Related]
34. Obesity as a risk factor in cancer: A national consensus of the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology.
Goday A; Barneto I; García-Almeida JM; Blasco A; Lecube A; Grávalos C; Martínez de Icaya P; de las Peñas R; Monereo S; Vázquez L; Palacio JE; Pérez-Segura P
Clin Transl Oncol; 2015 Oct; 17(10):763-71. PubMed ID: 26036853
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms involved in obesity-associated insulin resistance: therapeutical approach.
Fernández-Veledo S; Nieto-Vazquez I; Vila-Bedmar R; Garcia-Guerra L; Alonso-Chamorro M; Lorenzo M
Arch Physiol Biochem; 2009 Oct; 115(4):227-39. PubMed ID: 19673658
[TBL] [Abstract][Full Text] [Related]
36. Insulin resistance and coronary heart disease.
Laakso M
Curr Opin Lipidol; 1996 Aug; 7(4):217-26. PubMed ID: 8883497
[TBL] [Abstract][Full Text] [Related]
37. Oral supplementation of propionyl-l-carnitine reduces body weight and hyperinsulinaemia in obese Zucker rats.
Mingorance C; Gonzalez del Pozo M; Dolores Herrera M; Alvarez de Sotomayor M
Br J Nutr; 2009 Oct; 102(8):1145-53. PubMed ID: 19545458
[TBL] [Abstract][Full Text] [Related]
38. Influence of insulin resistance on adiponectin receptor expression in breast cancer.
Pfeiler G; Treeck O; Wenzel G; Goerse R; Hartmann A; Schmitz G; Ortmann O
Maturitas; 2009 Jul; 63(3):253-6. PubMed ID: 19524379
[TBL] [Abstract][Full Text] [Related]
39. Insulin resistance and hyperinsulinaemia in the development and progression of cancer.
Godsland IF
Clin Sci (Lond); 2009 Nov; 118(5):315-32. PubMed ID: 19922415
[TBL] [Abstract][Full Text] [Related]
40. [Obesity-related hypertension].
Ueda Y; Aoi W
Ryoikibetsu Shokogun Shirizu; 1996; (12):163-6. PubMed ID: 9047433
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
